Related Experiment Videos

Experimental model for human intestinal microsporidiosis in interferon gamma receptor knockout mice infected by

A Achbarou1, C Ombrouck, T Gneragbe

  • 1INSERM U. 313, CHU Pitié Salpêtrière, Paris, France.

Parasite Immunology
|August 1, 1996
PubMed

Insights

Interferon gamma (IFN-gamma) is crucial for controlling Encephalitozoon intestinalis, a cause of intestinal microsporidiosis. This study establishes a mouse model for evaluating new treatments against this chronic infection.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Parasitology

Background:

  • Encephalitozoon intestinalis causes intestinal microsporidiosis, particularly in immunocompromised individuals like AIDS patients.
  • Interferon gamma (IFN-gamma) signaling is a key component of the host immune response against intracellular pathogens.

Purpose of the Study:

  • To investigate the role of IFN-gamma in controlling Encephalitozoon intestinalis infection.
  • To establish and characterize a mouse model for studying chronic intestinal microsporidiosis and evaluating therapeutic agents.

Main Methods:

  • Encephalitozoon intestinalis spores were inoculated into interferon gamma receptor knockout (KO) mice and wild-type (WT) mice.
  • Infection was monitored for six months by quantifying parasite spores in feces, histological examination, and assessing infection sites.
  • Dose-response effects were evaluated by varying parasite inoculation quantities.

Main Results:

  • IFN-gamma receptor KO mice developed chronic E. intestinalis infections with higher spore excretion and more infection sites compared to WT mice.
  • WT mice showed a decrease in spore excretion by day 16 post-inoculation, with sporadic detection thereafter.
  • A clear dose-response relationship was observed, with higher parasite doses leading to increased infection severity.

Conclusions:

  • IFN-gamma plays a critical role in the immune control of Encephalitozoon intestinalis infection.
  • The developed mouse model, characterized by chronic infection and measurable spore shedding, is suitable for testing novel therapeutic strategies against E. intestinalis.

Related Concept Videos